PRAC Confirms No Difference in Risk Between Hemophilia A Drugs PRAC Confirms No Difference in Risk Between Hemophilia A Drugs

The EMA ' s Pharmacovigilance Risk Assessment Committee has confirmed its earlier conclusion that factor VIII medications do not differ in their risk for inhibition.News Alerts
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news